CD34 and neoplasm: As at diagnosis, almost all CD34+ cells are Ph1-positive45 and their number correlates with the tumour mass and therapeutic response46, our findings indicate that nilotinib uptake by mature malignant cells is inversely correlated with the tumour mass.